Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NVCN

Neovasc (NVCN) Stock Price, News & Analysis

Neovasc logo

About Neovasc Stock (NASDAQ:NVCN)

Advanced Chart

Key Stats

Today's Range
$30.03
$30.03
50-Day Range
$29.03
$30.03
52-Week Range
$4.59
$30.07
Volume
1 shs
Average Volume
56,993 shs
Market Capitalization
$82.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NVCN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neovasc and its competitors with MarketBeat's FREE daily newsletter.

NVCN Stock News Headlines

Closing Bell: Neovasc Inc down on Tuesday (NVCN)
Closing Bell: Neovasc Inc up on Monday (NVCN)
Crypto Income (almost instantly)
How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? Depending on when you watch this new training, crypto income could be hitting your account as early as tonight!
Neovasc Announces German Reimbursement Renewal
See More Headlines

NVCN Stock Analysis - Frequently Asked Questions

Neovasc Inc. (NASDAQ:NVCN) released its quarterly earnings results on Tuesday, November, 9th. The medical equipment provider reported ($2.75) earnings per share (EPS) for the quarter, missing the consensus estimate of ($2.25) by $0.50. The medical equipment provider earned $0.70 million during the quarter, compared to analyst estimates of $1.20 million. Neovasc had a negative net margin of 1,082.92% and a negative trailing twelve-month return on equity of 127.25%.

Neovasc's stock reverse split on Friday, April 29th 2022.The 1-25 reverse split was announced on Friday, April 29th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 29th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Neovasc investors own include Biopharmx (BPMX), Allstate (ALL), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Micron Technology (MU) and Canopy Growth (CGC).

Company Calendar

Last Earnings
11/09/2021
Today
8/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:NVCN
CIK
1399708
Employees
49
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($15.08)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$41.20 million
Net Margins
-1,082.92%
Pretax Margin
-1,082.26%
Return on Equity
-127.25%
Return on Assets
-80.31%

Debt

Debt-to-Equity Ratio
0.80
Current Ratio
2.96
Quick Ratio
2.85

Sales & Book Value

Annual Sales
$3.81 million
Price / Sales
21.60
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.77 per share
Price / Book
5.20

Miscellaneous

Outstanding Shares
2,740,000
Free Float
N/A
Market Cap
$82.28 million
Optionable
Not Optionable
Beta
1.70

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:NVCN) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners